MedPath

The Effect of Ischaemic-Reperfusion and Ischaemic Preconditioning on the Endogenous Fibrinolysis in Man

Not Applicable
Completed
Conditions
Ischaemic Heart Diseases
Registration Number
NCT00789243
Lead Sponsor
University of Edinburgh
Brief Summary

Heart attacks are usually caused by a blood clot blocking an artery supplying blood to the heart. Current treatments are designed at relieving this blockage as quickly as possible to minimise damage to the heart muscle. However in restoring the supply of blood local damage known as "ischaemia-reperfusion injury" may occur. The aim of this study is to assess how clot forming and clot dissolving pathways are affected during this process, and examine the role of a natural inflammatory hormone, bradykinin. This will help us to understand the mechanism by which ischaemia-reperfusion injury may occur and to devise new treatments for heart attacks.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
12
Inclusion Criteria
  • Healthy males between 18-65 years of ages, non-smokers.
Exclusion Criteria
  • Any concurrent illness or chronic medical condition. Concurrent use of vasoactive medication. Smoking history.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Net t-PA release from the endothelium after ischaemia reperfusion and ischaemic preconditioningThroughout the study
Secondary Outcome Measures
NameTimeMethod
Change in forearm blood flow after ischaemia reperfusion and ischaemic preconditioningthroughout the study
Change in platelet-monocyte-binding after ischaemia reperfusion and ischaemic preconditioningThroughout the study

Trial Locations

Locations (1)

University of Edinburgh, 49 Little France Crescent

🇬🇧

Edinburgh, United Kingdom

University of Edinburgh, 49 Little France Crescent
🇬🇧Edinburgh, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.